Terms: = Leukemia AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Treatment
54 results:
1. Contrast-enhanced CT-based radiomics differentiate anterior mediastinum lymphoma from thymoma without myasthenia gravis and calcification.
Huang X; Wang X; Liu Y; Wang Z; Li S; Kuang P
Clin Radiol; 2024 Apr; 79(4):e500-e510. PubMed ID: 38242804
[TBL] [Abstract] [Full Text] [Related]
2. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.
Mori T; Osumi T; Kada A; Ohki K; Koga Y; Fukano R; Fujita N; Mitsui T; Mori T; Saito AM; Nakazawa A; Kobayashi R; Sekimizu M
Eur J Haematol; 2024 Apr; 112(4):585-593. PubMed ID: 38112205
[TBL] [Abstract] [Full Text] [Related]
3. Effects of exercise training on cancer patients undergoing neoadjuvant treatment: A systematic review.
Malveiro C; Correia IR; Cargaleiro C; Magalhães JP; de Matos LV; Hilário S; Sardinha LB; Cardoso MJ
J Sci Med Sport; 2023 Nov; 26(11):586-592. PubMed ID: 37696693
[TBL] [Abstract] [Full Text] [Related]
4. Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia.
Johnson PC; Woyach JA; Ulrich A; Marcotte V; Nipp RD; Lage DE; Nelson AM; Newcomb RA; Rice J; Lavoie MW; Ritchie CS; Bartlett N; Stephens DM; Ding W; Owen C; Stone R; Ruppert AS; Mandrekar SJ; Byrd JC; El-Jawahri A; Le-Rademacher J; Rosko A
J Geriatr Oncol; 2023 Jul; 14(6):101538. PubMed ID: 37329769
[TBL] [Abstract] [Full Text] [Related]
5. Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study.
Wu S; Liu Y; Williams M; Aguilar C; Ramirez AG; Mesa R; Tomlinson GE
PLoS One; 2023; 18(4):e0278354. PubMed ID: 37022991
[TBL] [Abstract] [Full Text] [Related]
6. Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation.
Attwa MW; Alanazi MM
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838629
[TBL] [Abstract] [Full Text] [Related]
7. Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.
Patel PA; DeGroote NP; Jackson K; Cash T; Castellino SM; Jaggi P; Esbenshade AJ; Miller TP
Cancer; 2022 Dec; 128(23):4129-4138. PubMed ID: 36238979
[TBL] [Abstract] [Full Text] [Related]
8. Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial.
Pagel JM; Soumerai JD; Reddy N; Jagadeesh D; Stathis A; Asch A; Salman H; Kenkre VP; Iasonos A; Llorin-Sangalang J; Li J; Zelenetz AD
Lancet Oncol; 2022 Aug; 23(8):1021-1030. PubMed ID: 35835137
[TBL] [Abstract] [Full Text] [Related]
9. Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
Rosenthal SH; Gerasimova A; Ma C; Li HR; Grupe A; Chong H; Acab A; Smolgovsky A; Owen R; Elzinga C; Chen R; Sugganth D; Freitas T; Graham J; Champion K; Bhattacharya A; Racke F; Lacbawan F
PLoS One; 2021; 16(4):e0243683. PubMed ID: 33909614
[TBL] [Abstract] [Full Text] [Related]
10. Molecular response to imatinib in patients with chronic myeloid leukemia in Tanzania.
Nasser A; Hussein A; Chamba C; Yonazi M; Mushi R; Schuh A; Luzzatto L
Blood Adv; 2021 Mar; 5(5):1403-1411. PubMed ID: 33666650
[TBL] [Abstract] [Full Text] [Related]
11. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
Aberuyi N; Rahgozar S; Pourabutaleb E; Ghaedi K
Curr Res Transl Med; 2021 Jan; 69(1):103269. PubMed ID: 33071214
[TBL] [Abstract] [Full Text] [Related]
12. [Efficacy and safety of hepatitis B re-vaccination in children after completion of chemotherapy and(or) hematopoietic stem cell transplantation].
Yuan Q; Zhou F; Zhang H; Cao Q; Chen WJ; Fei Y; Luo CY; Gao YJ
Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):802-806. PubMed ID: 32987458
[No Abstract] [Full Text] [Related]
13. Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib.
Sun C; Nierman P; Kendall EK; Cheung J; Gulrajani M; Herman SEM; Pleyer C; Ahn IE; Stetler-Stevenson M; Yuan CM; Maric I; Gaglione EM; Harris HM; Pittaluga S; Wang MH; Patel P; Farooqui MZH; Izumi R; Hamdy A; Covey T; Wiestner A
Blood; 2020 Jul; 136(1):93-105. PubMed ID: 32202637
[TBL] [Abstract] [Full Text] [Related]
14. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiological Aspects and Risk Factors].
Ouldamer L; Body G; Daraï E; Bendifallah S
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):239-247. PubMed ID: 32004787
[TBL] [Abstract] [Full Text] [Related]
15. Mitotic slippage: an old tale with a new twist.
Sinha D; Duijf PHG; Khanna KK
Cell Cycle; 2019 Jan; 18(1):7-15. PubMed ID: 30601084
[TBL] [Abstract] [Full Text] [Related]
16. Megakaryocytic leukemia 1 (MKL1) mediates high glucose induced epithelial-mesenchymal transition by activating LOX transcription.
Ding Y; Xu H; Li L; Yuan Y; Xu Y
Biochem Biophys Res Commun; 2019 Feb; 509(3):633-640. PubMed ID: 30553442
[TBL] [Abstract] [Full Text] [Related]
17. Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients.
de Queiroz Mendonca C; Freire MV; Viana SS; Silva Tavares MKG; Almeida Silva WM; Cipolotti R
Leuk Res; 2019 Jan; 76():24-28. PubMed ID: 30513404
[TBL] [Abstract] [Full Text] [Related]
18. Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study.
Franiak-Pietryga I; Maciejewski H; Ziemba B; Appelhans D; Voit B; Robak T; Jander M; Treliński J; Bryszewska M; Borowiec M
Macromol Biosci; 2017 Nov; 17(11):. PubMed ID: 28762636
[TBL] [Abstract] [Full Text] [Related]
19. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
[TBL] [Abstract] [Full Text] [Related]
20. [Analysis of Risk Factors and Therapeutic Strategies for Relapse of leukemia after Allogeneic Hematopoietic Stem Cell Transplantation].
Shu XY; Yan XF; Dong L; Ding L; Han DM; Xue M; Wang ZD; Yan HM; Wang HX; Duan LN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1137-42. PubMed ID: 27531789
[TBL] [Abstract] [Full Text] [Related]
[Next]
